✦ LIBER ✦

Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer

✍ Scribed by M. VERHAAR-LANGEREIS; A. KARAKUS; M. Van EIJKEREN; E. VOEST; E. WITTEVEEN

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I dose-finding study of a combin

✍ Gibbs, D D; Pyle, L; Allen, M; Vaughan, M; Webb, A; Johnston, S R D; Gore, M E 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

A pilot study evaluating the efficacy an

✍ Faruk Tas; Nese Guney; Duygu Derin; Adnan Aydiner; Erkan Topuz 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 208 KB

Phase II study of liposomal doxorubicin

✍ D'Agostino, G; Ferrandina, G; Ludovisi, M; Testa, A; Lorusso, D; Gbaguidi, N; Br 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB

Phase II study of liposomal annamycin in

✍ Daniel J. Booser; Francisco J. Esteva; Edgardo Rivera; Vicente Valero; Laura Esp 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 56 KB

Phase I study of pegylated liposomal dox

✍ Fracasso, P M; Blum, K A; Ma, M K; Tan, B R; Wright, L P; Goodner, S A; Fears, C 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 124 KB

Pegylated liposomal doxorubicin in combi

✍ Alessandra Fabi; Gianluigi Ferretti; Paola Papaldo; Nello Salesi; Mariangela Cic 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 242 KB